🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Schizophrenia Disorder

Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients NCT05329363NA11 sites📍 Blois📍 Chinon📍 Dreux University Hospital, Tours · Tests: PEPITS Programme, Usual care Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia NCT07288333Phase 26 sites📍 Kazanlak📍 Pazardzhik📍 Targovishte Neurocrine Biosciences · Tests: NBI-1117570, Placebo Feeling Safe Study NCT07234708NA1 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Sentirnos Seguros Exercise and Olanzapine-samidorphan NCT06740890Phase 41 site📍 New York New York State Psychiatric Institute · Tests: Olanzapine-samidorphan + exercise Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis NCT07786714NA1 site📍 Verdun Douglas Mental Health University Institute · Tests: Active Intermittent Theta Burst Stimulation (BEAM-F3 Targeting), Sham Comparator: Sham iTBS A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults NCT06508450NA1 site📍 The Bronx New York University · Tests: Just Do You, Component A, Component B, Component C tACS for Self-Other Boundary in Schizophrenia NCT07818668NA1 site📍 Hefei Chunyan Zhu · Tests: Transcranial Alternating Current Stimulation (tACS), Sham Transcranial Alternating Current Stimulation (tACS) Exercise Therapy in Mental Disorders-study NCT06313918NA1 site📍 Bergen Haukeland University Hospital · Tests: High intensity training (HIT) Synergy Between Physical Activity and Outdoor Green Environments to Reduce the Intensity of Negative Symptoms in Schizophrenia. NCT07058389NA1 site📍 Saint-Etienne Centre Hospitalier Universitaire de Saint Etienne · Tests: 8-week outdoor physical activity program, 8-week indoor physical activity program Semantic and Syntactic Computerized Analysis of Free Speech NCT03525054n/a3 sites📍 Brest📍 Caen📍 Paris University Hospital, Brest Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia NCT07060066NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Active rTMS stimulation, Sham rTMS stimulation Time and Virtual Reality in Schizophrenia and Bipolar Disorder NCT04432116NA1 site📍 Strasbourg Institut National de la Santé Et de la Recherche Médicale, … · Tests: virtual reality 1, virtual reality 2 French Validation of Schizophrenia Proneness Instrument- Child Youth NCT06649552NA3 sites📍 Lille📍 Nancy📍 Saint-Egrève Centre Psychothérapique de Nancy · Tests: Psychiatric and psychological diagnostic tests Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia NCT07557368NA1 site📍 Shanghai Shanghai Mental Health Center · Tests: Gamified Digital Rehabilitation Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode NCT05384392NA5 sites📍 Angers📍 Brest📍 Nantes University Hospital, Brest · Tests: Recorded interview, Clinical scales, Blood sample The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. NCT05958875Phase 413 sites📍 Innsbruck📍 Augsburg📍 Bielefeld Dr. Inge Winter · Tests: Clozapine, Second-line Antipsychotics (treatment as usual) Taking Action for College Students NCT06700902NA1 site📍 Philadelphia Temple University · Tests: Taking Action A Long-term Administration Trial of SEP-363856 in Patients With Schizophrenia NCT07225712Phase 31 site📍 Fukuoka Otsuka Pharmaceutical Co., Ltd. · Tests: SEP-363856 Tolerability of MDMA in Schizophrenia NCT05770375Phase 1, Phase 21 site📍 Los Angeles Anya Bershad, MD, PhD · Tests: MDMA 40mg, MDMA 80mg, MDMA 120mg Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans NCT06058702Phase 11 site📍 West Haven Yale University · Tests: Delta-9-THC Very Low Dose, Placebo, Delta-9-THC Medium Dose The ATP Project (Antipsychotic-TEP-Psychosis) NCT06651112n/a1 site📍 Sherbrooke Université de Sherbrooke · Tests: Antipsychotic drugs Medial-prefrontal Enhancement During Schizophrenia Systems Imaging NCT04807530NA1 site📍 San Francisco University of California, San Francisco · Tests: TMS Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia NCT07428460NA3 sites📍 Montreal📍 Québec📍 Verdun Douglas Mental Health University Institute · Tests: Neuronavigated Intermittent Theta Burst Stimulation, BEAM-F3 Intermittent theta burst stimulation, Sham Intermittent Th… Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis NCT07001878Phase 42 sites📍 St. John's📍 Halifax Nova Scotia Health Authority · Tests: Metformin Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy NCT07098169NA3 sites📍 San Diego📍 Miami📍 Dallas University of California, San Diego · Tests: iTEST, Active Control Mechanisms of Response to Therapeutic Intervention in Clinical High Risk (CHR) for Psychosis NCT06542640NA1 site📍 Shanghai Beth Israel Deaconess Medical Center · Tests: Mb-rt-fMRI-NFB, Sham mb-rt-fMRI-NFB, rTMS, Sham rTMS Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients NCT05365347NA1 site📍 Halifax Nova Scotia Health Authority · Tests: Cognitive Enhancement Therapy (CET) rTMS for Depressive, Positive and Negative Symptoms, and Physiological Indices of Schizophrenia Patients NCT05671185NA1 site📍 Douliu, Yunlin National Taiwan University Hospital · Tests: Repetitive Transcranial Magnetic Stimulation Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia NCT07055204NA6 sites📍 Bayonne📍 Bron📍 Marseille University Hospital, Toulouse · Tests: "Diapason & Metronome" musical learning Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison NCT07265180NA1 site📍 Berlin Charite University, Berlin, Germany · Tests: Oxytocin, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy